| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 62135-641-31 | 62135-641 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA212041 | Chartwell RX, LLC | LISINOPRIL | 5 mg/1 | 300 TABLET in 1 BOTTLE (62135-641-31) |
| 62135-641-90 | 62135-641 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA212041 | Chartwell RX, LLC | LISINOPRIL | 5 mg/1 | 90 TABLET in 1 BOTTLE (62135-641-90) |
| 62135-642-31 | 62135-642 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA212041 | Chartwell RX, LLC | LISINOPRIL | 10 mg/1 | 300 TABLET in 1 BOTTLE (62135-642-31) |
| 62135-642-90 | 62135-642 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA212041 | Chartwell RX, LLC | LISINOPRIL | 10 mg/1 | 90 TABLET in 1 BOTTLE (62135-642-90) |
| 62135-640-31 | 62135-640 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA212041 | Chartwell RX, LLC | LISINOPRIL | 2.5 mg/1 | 300 TABLET in 1 BOTTLE (62135-640-31) |
| 62135-640-90 | 62135-640 | HUMAN PRESCRIPTION DRUG | Lisinopril | Lisinopril | TABLET | ORAL | 20230607 | N/A | ANDA | ANDA212041 | Chartwell RX, LLC | LISINOPRIL | 2.5 mg/1 | 90 TABLET in 1 BOTTLE (62135-640-90) |